BioHealth News Archive

TEDCO reaches ‘dramatic crossroads,’ taking on 5 times more venture responsibility – Baltimore Business Journal

TEDCO reaches ‘dramatic crossroads,’ taking on 5 times more venture responsibility – Baltimore Business Journal

Maryland Technology Development Corp.’s new board chair, Newt Fowler, is stepping in as the investment agency’s responsibility grows five-fold. TEDCO this year will take…

Read More
Silver Spring-based United Therapeutics gets boost from new drug – Washington Business Journal

Silver Spring-based United Therapeutics gets boost from new drug – Washington Business Journal

Silver Spring-based United Therapeutics' quarterly sales got a boost from its newest treatment for pulmonary arterial hypertension, while higher research and development costs, and…

Read More
MedImmune Embraces Translational Sciences – Cambridge News

MedImmune Embraces Translational Sciences – Cambridge News

The term 'translational sciences' means different things to different people. For MedImmune, the global biologics research and development arm of AstraZeneca, the term refers…

Read More
TEDCO board names new officers – Baltimore Business Journal

TEDCO board names new officers – Baltimore Business Journal

Newt Fowler, a longtime advisor and business planner for Baltimore entrepreneurs and investors, has been named chair of the Maryland Technology Development Corp. Fowler,…

Read More
NIST Draws up Guidelines for Protecting Medical Patient Data on Mobile Devices – Nextgov.com

NIST Draws up Guidelines for Protecting Medical Patient Data on Mobile Devices – Nextgov.com

The federal government is attempting to ensure that doctors don't inadvertently compromise patient data when they use smartphones to access electronic health records.  The National Institutes…

Read More
Top 15 Corporate Venture Funds – GEN

Top 15 Corporate Venture Funds – GEN

The shift from fully integrated pharmaceutical companies (FIPCOs) to virtually integrated pharma companies (VIPCOs) has made biopharmas more reliant on external R&D. Often, that…

Read More
Baxalta completes Oncaspar portfolio acquisition from Sigma-Tau Finanziaria

Baxalta completes Oncaspar portfolio acquisition from Sigma-Tau Finanziaria

Baxalta Incorporated, a $6 billion global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, has completed the…

Read More
Information Session: Relevant Health – Hosted by BHI

Information Session: Relevant Health – Hosted by BHI

Wednesday, August 5, 2015 from 5:00 PM to 7:00 PM (EDT) The Washington DC region is part of an east coast corridor rich in…

Read More
Medimmune, Sheffield University to research in cell factory technology – Pharmaceutical Business Review

Medimmune, Sheffield University to research in cell factory technology – Pharmaceutical Business Review

AstraZeneca's global biologics R&D arm MedImmune has entered into a five-year multi-project research collaboration with the University of Sheffield to carry out breakthrough research…

Read More
Johns Hopkins University leads the top 5 employers in Greater Baltimore – Baltimore Business Journal

Johns Hopkins University leads the top 5 employers in Greater Baltimore – Baltimore Business Journal

Johns Hopkins University tops the list of private, non-government employers in the Baltimore region, although three of the top five Baltimore-area employers are health…

Read More
MedImmune partners with the University of Sheffield to generate innovations in cell factory engineering science | More News | News Channels

MedImmune partners with the University of Sheffield to generate innovations in cell factory engineering science | More News | News Channels

MedImmune, the global biologics research and development arm of AstraZeneca, and the University of Sheffield announced today that they have entered into a multi-project…

Read More
Connecticut bioscience fund widens eligibility – Westfair Communications

Connecticut bioscience fund widens eligibility – Westfair Communications

Bioscience companies up to 7 years old can now apply for state funding that was formerly available only to younger companies. BioInnovation Connecticut, managed…

Read More
Therapeutic Financing Rounds in 2015: Gene Therapy Outpaces Antibodies in Early Stage Investment | NEXT PHASE

Therapeutic Financing Rounds in 2015: Gene Therapy Outpaces Antibodies in Early Stage Investment | NEXT PHASE

It is no secret that 2015 has been a highly active year for deal-making in the life science space.  However, what is often overlooked…

Read More
The Venture Funding Boom In Biotech: A Few Things It’s Not

The Venture Funding Boom In Biotech: A Few Things It’s Not

Venture-backed biotechs continue their blistering pace of funding. According to the latest MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), with data from Thomson…

Read More
Building the Health Tech Capital Tickets, Washington – Hosted by Relevant Health

Building the Health Tech Capital Tickets, Washington – Hosted by Relevant Health

Thursday, July 30, 2015 from 6:30 PM to 8:30 PM (EDT) Washington, DC The Washington DC region is part of an east coast corridor…

Read More